ALIVUS
Invest with MTF
Invest Now
Invest in Alivus Life Sciences with 3.18X leverage
Performance
- Low
- ₹862
- High
- ₹877
- 52 Week Low
- ₹847
- 52 Week High
- ₹1,251
- Open Price₹877
- Previous Close₹882
- Volume8,611
- 50 DMA₹903.75
- 100 DMA₹923.76
- 200 DMA₹952.58
Investment Returns
- Over 1 Month -3.88%
- Over 3 Month -6.32%
- Over 6 Month -18.27%
- Over 1 Year -20.23%
Smart Investing Starts Here Start SIP with Alivus Life Sciences for Steady Growth!
Alivus Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20
- PEG Ratio
- 0.8
- Market Cap Cr
- 10,611
- P/B Ratio
- 3.5
- Average True Range
- 23.18
- EPS
- 43.23
- Dividend Yield
- 0.6
- MACD Signal
- -1.27
- RSI
- 44.53
- MFI
- 30.15
Alivus Life Sciences Financials
Alivus Life Sciences Technicals
EMA & SMA
Current Price
₹864.95
-17.4
(-1.97%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹896.19
- 50 Day
- ₹903.75
- 100 Day
- ₹923.76
- 200 Day
- ₹952.58
Resistance and Support
882.97
- R3 919.78
- R2 907.72
- R1 895.03
- S1 870.28
- S2 858.22
- S3 845.53
Alivus Life Sciences Corporate Actions - Bonus, Splits, Dividends
Alivus Life Sciences F&O
About Alivus Life Sciences
- NSE Symbol
- ALIVUS
- BSE Symbol
- 543322
- Managing Director & CEO
- Dr. Yasir Rawjee
- ISIN
- INE03Q201024
Similar Stocks to Alivus Life Sciences
Alivus Life Sciences FAQs
Alivus Life Sciences share price is ₹864 As on 19 January, 2026 | 09:49
The Market Cap of Alivus Life Sciences is ₹10611.3 Cr As on 19 January, 2026 | 09:49
The P/E ratio of Alivus Life Sciences is 20 As on 19 January, 2026 | 09:49
The PB ratio of Alivus Life Sciences is 3.5 As on 19 January, 2026 | 09:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.